Dermatology, Dermapathology · New City, NY
NPI
1780670927
Since 2005
Specialty
Dermatology, Dermapathology
Code 207ND0900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
301 N Main St, Suite 3
New City, NY, 10956
Phone (845) 499-2017
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
21,017 services
Medicare patients, 2024
2,289
Average age 76
Drug cost, 2024
$3.9M
4,214 prescriptions
Company payments, 2025
$7,180
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott Sanders was code 17003 (destruction skin lesion), 4,446 times for 759 patients. In total Scott Sanders billed 21,017 services in 73 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,446 | 759 | $6.05 | $27K |
| 99213 Office E&M - Established | Office | 3,151 | 1,901 | $76.59 | $241K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 2,900 | 13 | $106.69 | $309K |
| 95044 Test - Miscellaneous | Office | 2,881 | 34 | $4.87 | $14K |
| 17000 Destruction Skin Lesion | Office | 1,190 | 947 | $40.92 | $49K |
| 17110 Destruction Skin Lesion | Office | 1,168 | 977 | $95.47 | $112K |
| 96920 Skin | Office | 1,074 | 40 | $139.52 | $150K |
| 11102 Skin Biopsy | Office | 861 | 734 | $71.52 | $62K |
| 96910 Skin | Office | 543 | 30 | $110.78 | $60K |
| 99214 Office E&M - Established | Office | 490 | 309 | $110.36 | $54K |
| 11103 Skin Biopsy | Office | 324 | 225 | $46.19 | $15K |
| 96921 Skin | Office | 311 | 15 | $154.12 | $48K |
| 99203 Office E&M - New | Office | 300 | 300 | $93.56 | $28K |
| 17004 Destruction Skin Lesion | Office | 251 | 186 | $151.92 | $38K |
| 10040 Removal or Shaving of Skin Growth | Office | 178 | 162 | $97.09 | $17K |
By year: 2022 $1.4M for 19,509 services; 2023 $1.3M for 18,765 services; 2024 $1.3M for 21,017 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 14 | 14 | $5.71 | $79.94 |
| 87101 General Laboratory | 13 | 13 | $7.56 | $98.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott Sanders prescribed most often to Medicare patients was Ketoconazole, with 432 prescriptions and refills. In total Scott Sanders wrote 4,214 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 432 | 490 | 210 | $7,133 |
| Triamcinolone Acetonide Generic | 382 | 427 | 271 | $3,995 |
| Clobetasol Propionate Generic | 328 | 344 | 167 | $13K |
| Mupirocin Generic | 276 | 289 | 208 | $2,094 |
| Hydrocortisone Generic | 225 | 239 | 151 | $1,191 |
| Halobetasol Propionate Generic | 206 | 214 | 139 | $11K |
| Metronidazole Generic | 179 | 209 | 90 | $9,100 |
| Minoxidil Generic | 167 | 488 | 68 | $1,537 |
| Fluorouracil Generic | 123 | 127 | 100 | $7,472 |
| Dupixent Pen Dupilumab | 123 | 159 | 23 | $611K |
| Dupixent Syringe Dupilumab | 120 | 192 | 19 | $713K |
| Nystatin Generic | 118 | 122 | 75 | $1,668 |
| Tacrolimus Generic | 108 | 111 | 58 | $18K |
| Doxycycline Hyclate Generic | 94 | 155 | 51 | $3,220 |
| Calcipotriene Generic | 84 | 93 | 61 | $12K |
Brand drugs: 780 claims; generic drugs: 3,434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott Sanders $7,180 ($7,180 in general payments such as food, travel and fees) from 21 companies. The largest payer was Janssen Biotech, Inc. with $1,500.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 54 | $1,500 |
| Abbvie Inc. ABBV | 47 | $921 |
| UCB, Inc. UCB.BR | 30 | $593 |
| Pfizer Inc. PFE | 36 | $532 |
| Genzyme Corporation SNY | 18 | $501 |
| Incyte Corporation INCY | 19 | $447 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $397 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 26 | $356 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $333 |
| Galderma Laboratories, L.P. GALD.SW | 34 | $256 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.